Published in BMC Microbiol on March 22, 2016
Microbiota of Chronic Diabetic Wounds: Ecology, Impact, and Potential for Innovative Treatment Strategies. Front Microbiol (2017) 0.75
Basic local alignment search tool. J Mol Biol (1990) 659.07
Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinformatics (2006) 43.68
UCHIME improves sensitivity and speed of chimera detection. Bioinformatics (2011) 29.22
Topographical and temporal diversity of the human skin microbiome. Science (2009) 15.96
FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics (2011) 13.71
Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol (2001) 11.67
A framework for human microbiome research. Nature (2012) 11.41
Preventing foot ulcers in patients with diabetes. JAMA (2005) 8.88
The global burden of diabetic foot disease. Lancet (2005) 6.58
The skin microbiome. Nat Rev Microbiol (2011) 5.78
Isolating "uncultivable" microorganisms in pure culture in a simulated natural environment. Science (2002) 5.70
Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabet Med (2012) 4.82
Biofilms in chronic wounds. Wound Repair Regen (2007) 4.02
Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol (2002) 3.57
2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis (2012) 3.22
Polymicrobial nature of chronic diabetic foot ulcer biofilm infections determined using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP). PLoS One (2008) 2.87
Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen (2008) 2.58
Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin Infect Dis (2010) 2.45
Polymicrobial interactions: impact on pathogenesis and human disease. Clin Microbiol Rev (2012) 2.14
Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents. J Clin Microbiol (2007) 1.97
Practical guidelines on the management and prevention of the diabetic foot 2011. Diabetes Metab Res Rev (2012) 1.97
Risk factors for foot infections in individuals with diabetes. Diabetes Care (2006) 1.96
Microbiology of the skin and the role of biofilms in infection. Int Wound J (2011) 1.92
Wound infection. A failure of wound healing caused by an imbalance of bacteria. Surg Clin North Am (1997) 1.80
Longitudinal shift in diabetic wound microbiota correlates with prolonged skin defense response. Proc Natl Acad Sci U S A (2010) 1.79
Bacterial fight-and-flight responses enhance virulence in a polymicrobial infection. Proc Natl Acad Sci U S A (2014) 1.70
Molecular methods for pathogen and microbial community detection and characterization: current and potential application in diagnostic microbiology. Infect Genet Evol (2012) 1.48
Genetic classification and distinguishing of Staphylococcus species based on different partial gap, 16S rRNA, hsp60, rpoB, sodA, and tuf gene sequences. J Clin Microbiol (2008) 1.47
Methicillin-resistant coagulase-negative staphylococcal osteomyelitis and its relationship to broad-spectrum oral antibiosis in a predominantly diabetic population. J Foot Ankle Surg (1996) 1.46
A comparison of bacterial composition in diabetic ulcers and contralateral intact skin. Open Microbiol J (2010) 1.39
The neuropathic diabetic foot ulcer microbiome is associated with clinical factors. Diabetes (2012) 1.31
Molecular microbiology: new dimensions for cutaneous biology and wound healing. J Invest Dermatol (2010) 1.28
Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem. Diabet Med (2003) 1.22
Bacterial load predicts healing rate in neuropathic diabetic foot ulcers. Diabetes Care (2007) 1.14
The use of antibiotics in the diabetic foot. Am J Surg (2004) 1.08
Antimicrobial Susceptibility Patterns of Pseudomonas aeruginosa from Diabetes Patients with Foot Ulcers. Int J Microbiol (2011) 1.02
First case of osteomyelitis caused by "Staphylococcus pettenkoferi". J Clin Microbiol (2007) 1.01
Risk factors for recurrent diabetic foot ulcers: site matters. Diabetes Care (2007) 0.97
Propagation of anaerobic bacteria within an aerobic multi-species chronic wound biofilm model. J Wound Care (2009) 0.96
Prevalence of Corynebacteria in diabetic foot infections. Diabetes Care (1992) 0.95
Management of diabetic foot ulcers. Diabetes Ther (2012) 0.95
Molecular and culture-based assessment of the microbial diversity of diabetic chronic foot wounds and contralateral skin sites. J Clin Microbiol (2012) 0.86
Identification of molecular mechanisms used by Finegoldia magna to penetrate and colonize human skin. Mol Microbiol (2014) 0.81
Treating diabetic foot osteomyelitis primarily with surgery or antibiotics: have we answered the question? Diabetes Care (2014) 0.80
Detection of anaerobic infection in diabetic foot ulcer using PCR technique and the status of metronidazole therapy on treatment outcome. Wounds (2012) 0.80
Classification, diagnosis, and treatment of diabetic foot ulcers. Wounds (2008) 0.79
Polymerase chain reaction-denaturing gradient gel electrophoresis (PCR-DGGE): a promising tool to diagnose bacterial infections in diabetic foot ulcers. Diabetes Metab (2014) 0.78
Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older males. Am J Geriatr Pharmacother (2004) 0.77